Lifespan partnership receives $2.7M grant for early-detection technology

LIFESPAN CORP. and California-based digital health company Eko have teamed up to develop a low-cost tool to diagnose pulmonary hypertension, with support from a $2.7 million Small Business Innovation Research grant. / COURTESY EKO
PROVIDENCE – Pulmonary hypertension, a type of high blood pressure, can have debilitating and deadly outcomes. But the “gold standard” for early detection is expensive and invasive, often leading to more than two-year delays in diagnosis and poorer outcomes. In an effort to make early detection more accessible, Lifespan Corp. and California-based digital health company Eko have teamed up to…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display